Skip to main content
Skip to content
Case File
kaggle-ho-024919House Oversight

Stock rating charts for GW Pharmaceuticals, Tilray, and Turning Point Brands

Stock rating charts for GW Pharmaceuticals, Tilray, and Turning Point Brands The document contains only historical price and target price data for three publicly traded companies, with no mention of influential individuals, government agencies, financial misconduct, or controversial actions. It offers no actionable leads for investigative work. Key insights: Shows closing and target price history for GW Pharmaceuticals, Tilray, and Turning Point Brands as of Feb 25, 2019.; Data sourced from BlueMatrix analytics platform.; Includes dates ranging from 2016 to early 2019.

Date
Unknown
Source
House Oversight
Reference
kaggle-ho-024919
Pages
1
Persons
0
Integrity
No Hash Available

Summary

Stock rating charts for GW Pharmaceuticals, Tilray, and Turning Point Brands The document contains only historical price and target price data for three publicly traded companies, with no mention of influential individuals, government agencies, financial misconduct, or controversial actions. It offers no actionable leads for investigative work. Key insights: Shows closing and target price history for GW Pharmaceuticals, Tilray, and Turning Point Brands as of Feb 25, 2019.; Data sourced from BlueMatrix analytics platform.; Includes dates ranging from 2016 to early 2019.

Tags

kagglehouse-oversightstock-marketfinancial-datapharmaceuticalscannabis-industrymarket-analysis

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.